Author: healthadmin

Recent research is Journal of Psychopharmacology This suggests that cannabidiol, a non-intoxicating compound found in cannabis, may not be an effective treatment for psychotic disorders. After analyzing data from multiple clinical trials, scientists found no significant evidence that the substance improved symptoms of psychosis compared to a placebo or standard drug. The findings indicate that although the compound is generally safe to use, patients and health care providers should view this compound as experimental rather than a proven treatment for these mental health conditions. Cannabis is a complex plant containing dozens of active compounds. The best known is delta-9-tetrahydrocannabinol (THC),…

In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain disease. Now, an international research team looking at the viral capsid has identified binding sites for neutralizing antibodies; these sites could be used to halt infection with JC polyomaviruses.テュービンゲン大学生化学学部生化学研究所のティロ・シュテーレ教授が主導するこの研究には、米国のブラウン大学とチューリッヒ病院の研究者も参加した。 JCポリオーマウイルスとヒトの免疫系との相互作用に関するこれらの新たな洞察は、治療法とワクチンの開発の基礎を築きます。 The study was published in the journal PNAS. neutralizing antibody Their bodies manage to neutralize the attacking JC polyomaviruses, so that they can no longer penetrate the body’s cells;感染は止まります。 ” Source link

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research Institute scientists, and IAVI has the potential to protect humans from HIV infection and the development of AIDS. For the first time, this HIV vaccine produces large amounts of “broadly neutralizing” antibodies that fight the virus in primates. “We feel this is a huge success,” says LJI Professor and Chief Scientific Officer Shane Crotty, Ph.D., who led the study with Scripps Research Professor William Sheeff, Ph.D. “We built a successful vaccine from scratch, which required a deep understanding of the immune system.” This groundbreaking research natureis…

As the body ages, changes in the bacteria living within the digestive system weaken the sensory connections between the gut and the brain, which can contribute to memory loss. By restoring normal communication along this physiological pathway in mice, researchers were able to reverse age-related cognitive decline and restore memory function. The experimental results were published in the journal Nature. Cognitive decline is one of the most common and challenging aspects of aging. As the average human lifespan increases, memory impairment has become a pressing issue for global health. Traditional research has historically focused on problems that occur directly within…

Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting more than 10 million people worldwide. Current treatments address the symptoms of the disease but cannot prevent the underlying neurodegeneration that causes the disease.Researchers from University Hospitals, Case Western Reserve University, and Louis Stokes Cleveland VA Medical Center previously identified new and promising drugs to treat neurodegenerative diseases such as Alzheimer’s disease (AD) and traumatic brain injury in a study published in the journal Science. Proceedings of the National Academy of Sciences (PNAS). The collaborative study, co-led by Andrew A. Pieper, MD, and Sanford Markowitz, MD, and awarded the…

NEW YORK — Over the past year, states across the country have seen significant declines in the number of people eligible for the Affordable Care Act, with Ohio and Oklahoma each losing nearly a third of their enrollees, according to new federal data that provides the first complete 50-state breakdown of the sharp decline in enrollment as enhanced subsidies expire in January. The data, released by the Trump administration in late June and first reported by The Associated Press, reveals how about 2.6 million fewer Americans had Obamacare plans in February compared to the same time last year, due to…

A new study has generated one of the most comprehensive spatially resolved transcriptome maps of cellular communication between bone and skeletal muscle in young mice. Researchers used spatial transcriptomics, computational deconvolution, and ligand-receptor network analysis to identify signaling pathways that coordinate tissue maintenance, remodeling, and vascular support. Significant interactions involving the collagen, thrombospondin, tenascin, and VEGF pathways were experimentally validated across independent datasets. This discovery provides a basis for studying musculoskeletal diseases and aging.Bone and skeletal muscle are often seen as separate tissues with different functions, but they function as a highly integrated system. They simultaneously support movement, maintain posture,…

In medicine, the smallest moments often mean the most, whether it’s a quiet conversation with a patient, a shared reflection with a colleague, or a hand held in silence. These brief but powerful connections, known as “sacred moments,” are the focus of a new study exploring their role in combating clinician burnout and strengthening patient trust. The study was led by the Lawson Institute, the research arm of St. Joseph’s Healthcare London (St. Joseph’s), and was recently published in a peer-reviewed paper. General Internal Medicine Journal The paper, titled “Sacred Moments in Healthcare: An Evidence-Based Conceptual Model,” outlines how sacred…

The federal judge overseeing a nationwide lawsuit involving claims that exposure to paraquat herbicides causes Parkinson’s disease is putting pressure on plaintiffs who won’t accept a settlement agreement proposed by paraquat maker Syngenta. U.S. District Judge Nancy Rosenstengel ordered plaintiffs who disagree with the terms of Syngenta’s settlement plan to meet with a “special presiding judge” by mid-July to ensure they make “an informed decision not to participate.” The judge also required many of the plaintiffs who chose to opt out of the settlement to take depositions by early August, along with “limited third-party discovery” related to their use of…

A new case report has been published in Volume 17. onco target July 2, 2026, titled “Renal Oncocytoma: Alpha Case Report and Literature Review.” The study was led by first author and corresponding author Areti Kalftsou of the Second Department of Internal Medicine, Aticon General Hospital, National Kapodistrian University of Athens, Greece. Renal oncocytoma is a rare benign tumor of the kidney that accounts for approximately 5-9% of renal epithelial tumors. Although it is considered benign, it closely resembles kidney cancer on imaging tests, making accurate diagnosis difficult. Because treatment strategies differ significantly between benign oncocytomas and malignant renal tumors,…